The National Institutes of Health (NIH) selected New York Genome Center’s Hemali Phatnani, PhD, as a recipient of its prestigious Director’s Transformative Research Award.
With this five-year, $8.5M grant, Dr. Phatnani will take an unconventional (but potentially groundbreaking) approach to ALS research.